Skin cancer drugs bring fresh hope.
A NEW mix of two different drugs can shrink skin cancer tumours by more than 80 per cent, say scientists.
Trials on patients led to a long-lasting reduction in the size of melanoma tumours within 12 weeks of treatment.
The combination of an immunotherapy drug called ipilimumab and the antibody drug nivolumab was reported in the New England Journal of Medicine.
Dr Jeff Wolchok, of New York's Memorial Sloan-Kettering Cancer Centre, said: "This kind of deep and rapid tumour regression has never been seen in melanoma using immunotherapy.
"It suggests that these two drugs could be better used in combination than alone."
|Printer friendly Cite/link Email Feedback|
|Publication:||Daily Record (Glasgow, Scotland)|
|Date:||Jun 3, 2013|
|Previous Article:||SMITH: I'M DOWN BUT NOT OUT; Bankrupt ex-Ger upbeat.|
|Next Article:||FLY WITH THE ANGELS.|